117 related articles for article (PubMed ID: 23804707)
1. A robust immunoassay for pregnancy-associated plasma protein-A2 based on analysis of circulating antigen: establishment of normal ranges in pregnancy.
Kløverpris S; Gaidamauskas E; Rasmussen LC; Overgaard MT; Kronborg C; Knudsen UB; Christiansen M; Kumar A; Oxvig C
Mol Hum Reprod; 2013 Nov; 19(11):756-63. PubMed ID: 23804707
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
[TBL] [Abstract][Full Text] [Related]
3. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A.
Wøjdemann KR; Larsen SO; Rode L; Shalmi A; Sundberg K; Christiansen M; Tabor A
Scand J Clin Lab Invest; 2006; 66(2):101-11. PubMed ID: 16537243
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
5. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview.
Kirkegaard I; Uldbjerg N; Oxvig C
Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1118-25. PubMed ID: 20804336
[TBL] [Abstract][Full Text] [Related]
6. Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence.
Gyrup C; Christiansen M; Oxvig C
Clin Chem; 2007 May; 53(5):947-54. PubMed ID: 17363418
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in mice.
Conover CA; Boldt HB; Bale LK; Clifton KB; Grell JA; Mader JR; Mason EJ; Powell DR
Endocrinology; 2011 Jul; 152(7):2837-44. PubMed ID: 21586553
[TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
Ong CY; Lee CP; Leung KY; Lau E; Tang MH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
[TBL] [Abstract][Full Text] [Related]
9. A substrate specificity-determining unit of three Lin12-Notch repeat modules is formed in trans within the pappalysin-1 dimer and requires a sequence stretch C-terminal to the third module.
Weyer K; Boldt HB; Poulsen CB; Kjaer-Sorensen K; Gyrup C; Oxvig C
J Biol Chem; 2007 Apr; 282(15):10988-99. PubMed ID: 17314100
[TBL] [Abstract][Full Text] [Related]
10. Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia.
Toop K; Klopper A
Placenta Suppl; 1981; 3():167-73. PubMed ID: 6191321
[TBL] [Abstract][Full Text] [Related]
11. A sensitive time-resolved fluoroimmunoassay for determination of median levels of pregnancy-associated plasma protein a in pregnant women in China.
Yu T; Gao S; Yin A; Tang Y; Wu Y; Li L; Li M
J Immunoassay Immunochem; 2013; 34(4):365-75. PubMed ID: 23859787
[TBL] [Abstract][Full Text] [Related]
12. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
[TBL] [Abstract][Full Text] [Related]
13. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia.
Hedley PL; Placing S; Wøjdemann K; Carlsen AL; Shalmi AC; Sundberg K; Tabor A; Christiansen M
Prenat Diagn; 2010 Feb; 30(2):103-9. PubMed ID: 20013873
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia.
Inagaki A; Nishizawa H; Ota S; Suzuki M; Inuzuka H; Miyamura H; Sekiya T; Kurahashi H; Udagawa Y
Placenta; 2012 Nov; 33(11):919-26. PubMed ID: 22964307
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
16. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.
Yaron Y; Heifetz S; Ochshorn Y; Lehavi O; Orr-Urtreger A
Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology.
Frystyk J; Teran E; Gude MF; Bjerre M; Hjortebjerg R
Growth Horm IGF Res; 2020; 53-54():101330. PubMed ID: 32693362
[TBL] [Abstract][Full Text] [Related]
18. First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia.
Crosley EJ; Durland U; Seethram K; MacRae S; Gruslin A; Christians JK
Reprod Sci; 2014 Jun; 21(6):754-60. PubMed ID: 24336677
[TBL] [Abstract][Full Text] [Related]
19. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
[TBL] [Abstract][Full Text] [Related]
20. Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia.
Kodama M; Miyoshi H; Fujito N; Samura O; Kudo Y
J Obstet Gynaecol Res; 2011 Apr; 37(4):313-8. PubMed ID: 21392164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
